Membrane fusogenic nanoparticle‐based HLA‐peptide‐addressing universal T cell receptor‐engineered T (HAUL TCR‐T) cell therapy in solid tumor

T cell receptor‐engineered T (TCR‐T) cell therapy has demonstrated therapeutic effects in basic research and clinical trials for treating solid tumors. Due to the peptide‐dependent recognition and the human leukocyte antigen (HLA)‐restriction, TCR‐T cell therapy is generally custom designed to targe...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ruihan, Wang, Qin, Zhu, Junmeng, Bei, Yuncheng, Chu, Yanhong, Sun, Zhichen, Du, Shiyao, Zhou, Shujuan, Ding, Naiqing, Meng, Fanyan, Liu, Baorui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658479/
https://www.ncbi.nlm.nih.gov/pubmed/38023696
http://dx.doi.org/10.1002/btm2.10585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658479/
https://www.ncbi.nlm.nih.gov/pubmed/38023696
http://dx.doi.org/10.1002/btm2.10585

Ejemplares similares